| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Cure Leukaemia We fund the Trials Acceleration Programme (TAP) which delivers & connects patients to blood cancer clinical trials. One person is diagnosed with blood cancer every 14 minutes. Help us to help save more lives and eradicate all forms of blood cancer within the next 15 years. Founded in 2003 by Professor Charlie Craddock CBE and patients Graham Silk and Michael Woolley, Cure Leukaemia helps to bring pioneering drug and transplant treatments to blood cancer patients across the United Kingdom. The charity has committed £3m from 2020-22 to fund the Trials Acceleration Programme (TAP) comprising a network of 12 blood cancer … Type: | 19 | 4 | 16 | 23 |
 | Parkinson's UK We’ll find a cure. Together. Powered by people. Funded by you. Improving life for everyone affected by Parkinson’s. Your mum, colleague or friend. Anyone can get Parkinson’s, young or old. Every hour, two more people are diagnosed. Unlocking new treatments means delving into the causes of Parkinson’s. That’s why we fund the Parkinson's UK Brain Bank – the world's only brain bank dedicated to Parkinson's research. Over 10,000 people have donated their brains to help scientists around the world to unravel the mysteries of the condition and develop better treatments. The largest charitable funder of Parkinson’s research in Europe, we’re … Type: | 23 | 4 | 14 | 644 |
 | Plasticell Limited Plasticell is a biotechnology company that develops novel therapies through precise manipulation of stem cells and more differentiated cell types using award-winning combinatorial screening technology. Technolgy Innovate cell-based combinatorial screening technology allows us to develop optimised protocols for cell expansion, cell differentiation, gene transduction, biomolecule production as well as the provision of human cells for use in drug discovery. Pipeline Out therapeutic projects include advanced cell and gene therapies as well as drugs discovered by screening rare human cell types derived from stem cells Visit our website www.plasticell.co.uk for more details. Stem Cell Research, Biotechnology, and High Throughput Stemcell Research Type: | 2 | 1 | 1 | 12 |
 | Metabolon, Inc. Providing actionable biological insights to answer the toughest questions in life sciences research and drug development Almost every factor that affects health – from genetics and the microbiome to disease and lifestyle – exerts its influence by altering metabolite levels in the body or other biological system. By producing the most accurate and comprehensive picture of the collection of metabolites, known as the metabolome, from a single biological sample, Metabolon can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the … Type: | 12 | 0 | 9 | 216 |
 | Family & Children's Aid, Inc. Improving children's emotional and behavioral health Family & Children's Aid (FCA) is a community-based, non-profit agency designed to help support and heal Connecticut's children, adolescents and their families by providing high quality emerging and evidence-based mental health services. FCA believes that seeking help is a sign of strength and that excellent care should be available to individuals and families in all walks of life, whenever needed and without discrimination. FCA’s clinical services reach throughout western Connecticut and include group homes for children and adolescents who have been removed from their home environments by the CT Department of Children and Families, … Type: | 1 | 0 | 1 | 172 |
 | Genedata Enterprise solutions to digitalize biopharma R&D Founded in 1997, Genedata delivers enterprise solutions to enable Biopharma R&D globally to discover, develop, and manufacture innovative biotherapeutics faster and more efficiently. Genedata combines computational, scientific, and technical expertise with extensive biopharma R&D domain knowledge to deliver user-friendly solutions that are scalable, open, and aligned with industry processes. Today, most of the leading pharmaceutical, biotechnology, and agrichemical companies, as well as innovative life science research institutions rely on Genedata. Genedata is proud to be part of Danaher. Danaher’s science and technology leadership puts Genedata’s solutions at the forefront of the industry, so they … Type: | 7 | 1 | 7 | 379 |
 | Reaction Biology Contract research organization with commitment to quality data and quality support. Let's Discover Together. Reaction Biology provides scientists worldwide with a trusted research partner supporting all phases of preclinical drug discovery from target validation through hit identification, hit to lead and lead optimization. Our portfolio covers most of your needs in drug discovery – over 2,000 biochemical targets, hundreds of cell-based assays, an extensive array of in vivo oncology models, along with custom assay development and protein production. Our team of Ph.D. scientists will provide you with collaborative support, quality data, and excellent communication, for a superior research result. Our … Type: | 4 | 1 | 3 | 144 |
 | MSD Portugal [Automatic translation follows] Inventing for Life We have done great things in the past. Today, we are doing great things for the future. Present in Portugal since 1970, MSD has been faithful to the principles of innovation and continuous improvement of people's health and well-being since its inception. As one of the largest pharmaceutical laboratories in the world and an active partner in all matters related to the area of health, MSD presents innovative solutions that contribute to preserving and improving the lives of millions of people. For over a century, MSD has been making discoveries to solve some of … Type: | 3 | 0 | 1 | 112 |
 | NCPE - National Centre for Pharmacoeconomics The NCPE conducts the Health Technology Assessment of pharmaceutical products for the Health Service Executive in Ireland in collaboration with the HSE Corporate Pharmaceutical Unit. The aim of the centre is to promote expertise in Ireland for the advancement of the discipline of pharmacoeconomics through practice, research and education. Visit our website at: www.ncpe.ie or follow us on Twitter at: @INFO_NCPE Health technology assessment, Health research, Education, Economic evaluation, Cost-effectiveness analysis, Critical appraisal, Evidence Synthesis, Health Type: | 3 | 0 | 1 | 19 |
 | Ajinomoto Bio-Pharma Services The Power to Make Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services for small and large molecule APIs and intermediates. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex® protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet … Type: | 3 | 0 | 0 | 774 |
 | Technoclone Technoclone is a producer of #diagnostic tests, equipment and research products in the area of #blood #clotting At Technoclone we see innovation as our duty to help overcome new complexity in the diagnostics of hematological and cardio-vascular disorders. Today more than ever. Technoclone is a world-leading producer of diagnostics tests; equipment’s and research products in the area of blood clotting and offers one of the most complete product portfolios on the market. The Ceveron 100 series is the first fully automated coagulation analyzer series for clotting, chromogenic, turbidimetric assays, thrombin generation and quenching technology (as for FXIII & ADAMTS13 activity). … Type: | 1 | 0 | 0 | 22 |
 | Tentamus Group Global Network of specialized Laboratories - Labs for Life For more than a decade the Tentamus Group has been providing services to customers all over the world. Our quality and safety services focus on the testing, auditing and consulting of products that influence human well-being from within. The Tentamus Group is valued by many companies as a true service partner for a wide range of products with a high degree of quality and local understanding. More than 90 laboratories with more than 4,000 highly qualified employees are part of the Tentamus Group worldwide. Regardless of the size of our group, … Type: | 3 | 0 | 0 | 1,020 |
 | Salvat Driven by innovation to contribute to a healthier and happier life We share a deep commitment to service and customer service, which, combined with our professionalism, helps us achieve our primary objective: giving a longer, healthier, happier life to society by offering safe and efficacious drugs. We are able to achieve this goal through research and analysis, as well as an understanding of the needs of our patients, professionals, distributors and institutional representatives. Medicamentos de prescripción, Nutraceuticos, and Productos farmacéuticos Type: | 1 | 0 | 0 | 358 |
 | peptides&elephants GmbH providing customized peptides , antigen peptides and peptidelibraries for immunological research peptides&elephants - We serve Peptides - for your perfect satisfaction with quality, price and support. Our major PEP-LIPS products are high parallel customized peptide libraries and peptide pools. PEP-LIPS are approved for T-Cell Stimulation Assays, Epitope Mapping, EliSpot Assays, Drug Discovery and Array Technology. The full range of Peptides and Peptidomimetica from the single to millions from linear to cyclic from short to overlong, from crude to high purity, from modified to labeled, from natural to non natural amino acids - peptides&elephants is your faithful partner. Please visit our … Type: | 3 | 0 | 2 | 6 |
 | Humanigen, Inc. Humanigen, Inc. (HGEN) is a clinical-stage biopharmaceutical company seeking to transform the treatment of cancers and infectious diseases, including COVID-19, by preventing and treating cytokine storm via its novel, cutting-edge anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody neutralization and gene-knockout platforms. Its proprietary Humaneered® monoclonal antibodies, designed to optimize antibody properties, show promise in prevention/treatment of cytokine storm induced by SARS-CoV-2 (COVID-19), chimeric antigen receptor T-cell (CAR-T) therapy and graft versus host disease (GvHD) by neutralizing GM-CSF which is up-regulated in these conditions. Type: | 4 | 0 | 3 | 6 |
 | Praxis Focused patient recruitment. At Praxis, we work hard to make connections that matter in our approach to patient recruitment and retention for important clinical trials. We have highly sophisticated analytics tools that connect our service driven experts with real insight – including patients’ thoughts and feelings. And this helps drive our strategy. We have a process that connects historic data to current goals. We craft targeted integrated campaigns that connect us with just the right patients. And creative tactics – digital, traditional, and video – that connect with those patients on a rational and emotional level. We have growing therapeutic … Type: | 10 | 0 | 7 | 56 |
 | The Science Advisory Board The source of discovery and development in the life sciences. The Science Advisory Board is a global community of scientists and medical professionals from around the world. Manufacturers of laboratory instruments and consumables, pharmaceutical and medical device companies, financial institutions and government agencies rely on the perspectives of our members when making important decisions. life science, molecular biology, cell biology, molecular diagnostics, drug discovery, bioprocessing, clinical chemistry, microbiology, proteomics, genomics, gene therapy, immunology, medicinal chemistry, stem cell biology, pathology, and analytical chemistry Type: | 26 | 1 | 26 | 11 |
 | AFFiRiS AG Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you. We are a clinical-stage biotechnology company that strives to challenge established treatment options for neurodegenerative diseases in order to preserve the quality of life of patients. WE FOCUS ON UNMET MEDICAL NEEDS IN CHRONIC DISEASES Currently available treatments for many neurodegenerative diseases aim to manage symptoms, and do not stop disease progression. As a result, neurodegenerative diseases often lead to a reduced quality of life. Better treatments for these diseases are needed to give patients healthier, happier, and longer lives. We aim to develop therapeutic and … Type: | 1 | 0 | 0 | 4 |
 | Intercept Pharmaceuticals Our mission is to build a healthier tomorrow for patients with rare and serious liver diseases. We are a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with rare and serious liver disease. We are committed to improving patients’ lives and addressing the liver community’s most pressing needs. Our corporate headquarters is … Type: | 5 | 1 | 0 | 388 |
 | Oxford BioTherapeutics Redefining the cancer-immune synapse for novel immune checkpoint mechanisms Oxford BioTherapeutics (OBT) is a clinical stage oncology company based in Oxford, UK; San Jose, CA and Morristown, NJ, USA, with a pipeline of first-in-class immuno-oncology (IO) and antibody-drug conjugate (ADC) based therapies designed to fulfil major unmet patient needs in cancer therapeutics. Our lead asset, OBT076, is an Antibody Drug Conjugate (ADC) in Phase 1b clinical development. OBT076's dual mechanism of action allows it to act as a 'primer' to re-engage the patient's immune system while at the same time targeting cancer cells directly. OBT’s proprietary OGAP® target discovery platform … Type: | 1 | 0 | 1 | 48 |
 |  Plio Surgical Novel GI Anastomosis — MedTech Innovator 2023 GI surgery innovation Type: | 4 | 1 | 0 | 2 |
 | NewBiologix Developing technologies for the biopharma industry to allow them to treat the root causes of diseases and disorders. Based in Lausanne, Switzerland, NewBiologix SA is a technology innovation company developing a proprietary and breakthrough DNA integration platform for the advanced engineering of human and mammalian cell lines for the improved production of viral vectors used in gene therapies. gene therapy, cell therapy, next-generation sequencing, NGS, rAAV, viral vectors, biologics, stable cell lines, Genomic Integration, stem cell, bioinformatics, capsid optimization, HEK293, gene expression, ATMPs, genomic, epigenetic, transcriptomic, mammalian cell lines, and human cell lines Type: | 0 | 0 | 0 | 22 |
 | CenExel A leading nationwide clinical research site network pursing life-changing therapies committed to better patient outcomes CenExel is a leading integrated, wholly owned, nationwide clinical research site network comprised of 18 Centers of Excellence in major metropolitan areas across the U. S. With 40+ years of experience, our Centers of Excellence deliver deep scientific expertise, premium data, operational efficiencies, and exceptional patient engagement to drive successful complex clinical trial outcomes. The world's most results-driven Pharma, Biotech, and Clinical Research Organizations trust our strategic approach and benefit from our collaboration and unified sites’ commitment to real world solutions. Rely on us to … Type: | 11 | 0 | 2 | 728 |
 | Grupo SANED [Automatic translation follows] It has a 40-year track record of providing information, training and research in the health sector. Grupo SANED has a track record of more than 40 years responding to the promotion needs of the pharmaceutical industry, developing projects for its marketing, medical, ebusiness, HR, market access departments, etc. More than 50 professionals integrated into its structure and more than 400 external collaborators (health communication experts, medical writers, marketing experts, healthcare managers, designers, programmers, etc.) are at your service to achieve your information, training and research objectives. Continuing medical training, development of inter and intra personal and management … Type: | 14 | 0 | 14 | 100 |
 | Kymos Group Analytical CRO devoted to bioanalysis and quality control of small molecules, biologics and nucleic acids Kymos is a CRO that provides development services for pharmaceutical, biotechnology, veterinary, fine chemistry, cosmetics and nutraceuticals industries. The main areas of activity are the following ones: i) Immunogenicity studies and immunoassay of innovative biological drugs, biosimilars and vaccines. ii) Bioanalysis in preclinical and clinical studies, including full bioequivalence studies. iii) Quality control, stability studies and analytical development of drug substances and drug products (physico-chemical and microbiological testing) iv) Process analytical technology services, using NIR and RAMAN and QbD strategies. Kymos is certified in GLP's … Type: | 11 | 1 | 1 | 175 |
 | Gentian Diagnostics We innovate diagnostic efficiency Gentian Diagnostics – a global medical diagnostics company – develops and manufactures high quality, in vitro diagnostic (IVD) reagents for a wide range of clinical chemistry analysers. Our product lines of laboratory tests, for diverse medical conditions, improve accuracy and provide faster results, for both human and veterinary healthcare. Gentian Diagnostics serves the global market for human and veterinary medical diagnostic tests via our OEM partners and key distributors. The Gentian HQ and production facility is in Moss, Norway. We also have a representative office in China and the distribution subsidiaries: Gentian USA, Inc. and Gentian … Type: | 1 | 0 | 0 | 62 |
 | Summit Pharmaceuticals International Corporation As one of core operating companies of the Sumitomo Corporation Group, we contribute to enriching lives and the world through the improvement of the health and well-being by linking pharmaceutical companies in Japan and overseas, leveraging its global network and expertise. Type: | 1 | 1 | 0 | 34 |
 | MSD Italia [Automatic translation follows] We have always invented for one great purpose: Life We have always invented for one great purpose: Life MSD, known in the United States and Canada as Merck & Co., Inc., with headquarters in Kenilworth, (New Jersey, USA), is an American multinational leader in the pharmaceutical sector. For over 65 years in Italy and 130 in the world, we have revolutionized therapeutic paradigms for dozens of pathologies through the discovery of over 200 innovative molecules. Our mission is to discover, develop, make available innovative products and services that save and improve the lives of Patients around the … Type: | 12 | 0 | 5 | 528 |
 | WCG We improve lives by accelerating research, together. WCG is a true partner to research sponsors, CROs, sites and participants in navigating the clinical research journey. The pioneer of independent ethical review, now the industry gold standard, WCG’s 55-year legacy of independent review solutions serves as the foundation on which we continually build to accelerate and improve the clinical research journey. We lead the way by reimagining processes, optimizing quality and safety, strengthening productivity, and pioneering new solutions that leverage data and technology to accelerate research and impact global health. WCG liberates study stakeholders from the constraints that risk trial efficacy … Type: | 2 | 0 | 2 | 1,333 |
 | FairJourney Biologics FairJourney Biologics, your end-to-end antibody partner At FairJourney Biologics, cutting-edge science meets unparalleled expertise in antibody discovery and development. As your leading end-to-end solutions partner for antibody solutions, we are committed to revolutionizing your research and fast-tracking the success of your programs. With top-tier technologies and a team of seasoned researchers, we take pride in delivering high-quality, reliable antibodies tailored to meet your unique demands. Drawing upon over a decade of extensive expertise in antibody discovery and development, we have achieved remarkable results, with at least 14 antibodies having advanced to clinical stages as a direct outcome of these endeavours. … Type: | 2 | 0 | 1 | 281 |
 | Dragonfly Therapeutics, Inc. Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas. For more information, email info@dragonflytx.com. immuno-oncology Type: | 4 | 0 | 1 | 127 |
 | AVROBIO Clinical-stage lentiviral gene therapy company, powered by plato®. Our vision: bring personalized gene therapy worldwide Our vision is to bring personalized gene therapy to the world. We target the root cause of genetic disease by introducing a functional copy of the affected gene into patients’ own hematopoietic stem cells (HSCs), with the goal of durably expressing the therapeutic protein throughout the body, including the central nervous system. Our first-in-class pipeline includes clinical programs for Gaucher disease and Hunter syndrome, as well as a preclinical program for Pompe disease. Our proprietary plato® gene therapy platform is scalable for planned global commercialization. … Type: | 3 | 1 | 0 | 24 |
 | Skyhawk Therapeutics We Use Small Molecules To Modify RNA Splicing Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that modify RNA expression. Our founders are leading experts in small molecule therapeutics development for RNA-based disease. Our first drug candidates are targeted toward cancers and neurological conditions. The company is based in Waltham, Massachusetts. For more information, please visit: www.skyhawktx.com. Type: | 3 | 0 | 1 | 70 |
 |  Korro Bio, Inc. Edit the message. Rewrite the future. Pioneering RNA editing to deliver the future of medicine. Korro Bio was founded to turn extraordinary scientific insights into life-altering new treatments for patients. We harness the body’s natural RNA editing machinery to make precise, single-base RNA edits to modulate protein function, addressing the medical needs of patients. Our mission is to rewrite the future for patients living with debilitating disease by repairing the underlying genetic cause. Type: | 3 | 0 | 2 | 105 |
 | Apollomics We are a biopharmaceutical company committed to the discovery and development of mono- and combination cancer therapies. Apollomics is an innovative biotechnology company committed to the discovery and development of oncology combination therapies. With operations in both the U.S. and China, we believe we are well positioned to unlock synergies by leveraging the strengths of partnerships with other biotechnology companies in the East and the West. Since our founding in 2015, under the leadership of our experienced management team with in-depth knowledge and expertise of the evolving cancer treatment landscape, we have built a pipeline of ten (10) drug candidates … Type: | 1 | 0 | 1 | 27 |
 | Poseida Therapeutics, Inc. The Capacity to Cure Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated allogeneic cell therapies and genetic medicines with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes investigational allogeneic CAR-T cell therapies for both solid tumors and hematologic cancers as well as investigational in vivo genetic medicines that address patient populations with high unmet medical need. The Company's approach is based on its proprietary genetic editing platforms, including its non-viral piggyBac® DNA Delivery System, Cas-CLOVERTM Site-Specific Gene Editing System, Booster Molecule and nanoparticle gene delivery technologies, as well as in-house GMP cell therapy manufacturing. … Type: | 3 | 0 | 3 | 343 |
 | Civica Rx Serving patients is a privilege that comes with significant responsibilities. Civica Rx was created in late 2018 to secure the supply of important medicines hospitals use every day. As of Q2 2024, we have provided over 180 million units of essential medicines to hospitals, enough to help treat over 80 million patients. Recently, we announced we will manufacture and distribute affordable medications for consumers in an outpatient/retail setting, including affordable insulin. Insulin is an exciting project as we are partnering with nearly every corner of the diabetes ecosystem to bring low-cost insulin to people living with diabetes at no more … Type: | 1 | 0 | 0 | 175 |
 | Abzena Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, … Type: | 7 | 0 | 1 | 448 |
 | Voyager Therapeutics, Inc. Breaking through barriers in gene therapy and neurology Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACERTM AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs … Type: | 3 | 0 | 2 | 203 |
 | NovioSense BV NovioSense BV is a spin out company from Fraunhofer Gesellschaft and NovioTech BV based in Nijmegen. NovioSense is a wireless platform technology for non-invasive monitoring of disease biomarkers. The first sensor based on the NovioSense technology is a wireless non-invasive glucose sensor. Development is targeted at a clinical prototype for non-invasive continuous monitoring of glucose levels in tear fluid. Medical Devices, Sensor Development, Diabetes, and Medical Technology Type: | 0 | 0 | 0 | N/A |
 | Precigen Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of gene and cell therapies. Precigen: Advancing Medicine with PrecisionTM Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and … Type: | 0 | 0 | 0 | 117 |
 | Sen-Jam Pharmaceutical We’re changing the way the world treats inflammation and the way the pharma industry treats humanity Join the revolution! We’re changing the way the world treats inflammation and the way the pharma industry treats humanity. Invest today → https://wefunder.com/senjam Sen-Jam's Global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monograph. It's time for a stronger, more resilient world, free of side-effects and filled with living remarkably Inflammation , Wellbeing, Pain Relief, pharmaceutical, and healthcare Type: | 0 | 0 | 0 | 8 |
 | InCarda Therapeutics Pioneering inhaled medications for cardiovascular conditions InCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The lead product under development is an inhaled therapy to treat a common atrial arrhythmia, paroxysmal atrial fibrillation (PAF). Cardiovascular, Inhalation therapy, Biotechnology, Pharmaceuticals, Clinical Development, Drug Formulation, Commercialization, Clinical Research, Pre-Clinical Research, and Regulatory Affairs Type: | 1 | 0 | 0 | 15 |
 | MindMed MindMed is a clinical-stage biopharma company developing novel products to treat brain health disorders MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems. MindMed trades on the NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the … Type: | 4 | 0 | 3 | 101 |
 | American Gene™ A cell & #genetherapy company with a #gene delivery platform to develop cures to #cancer #HIV #PKU. In Phase 1 trial for #HIVcure. CEO @JeffreyGalvin. Type: | 1 | 0 | 0 | N/A |
 | Insmed Incorporated Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. We are dedicated to making a meaningful impact in patients’ lives as well as the communities where we live and work. Our team is guided by our core values of collaboration, accountability, passion, respect, and integrity. Insmed is headquartered in Bridgewater, NJ, and has offices and research locations throughout the United States, Europe, and Japan. We are proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending three consecutive years as … Type: | 3 | 0 | 2 | 1,156 |
 | Crinetics Pharmaceuticals Discovering drugs for endocrine diseases and endocrine-related tumors. #acromegaly #crinetics #CarcinoidSyndrome This place is about more than a pharmaceutical career. It’s about making a real difference in the lives of patients. That’s why we’re here. That’s why you should maybe think about being here, too. Our mission is to build the leading endocrine company that consistently pioneers new therapeutics to help patients better control their disease and improve their daily lives. Working to accomplish this mission is how we bring our vision to life. For us, that vision is the best possible therapeutics available to all patients with diseases of … Type: | 3 | 0 | 1 | 336 |
 | HANSAmed Limited To serve our community and better the lives of dental patients. HANSAmed is a specialty dental pharmaceutical and medical device distributor serving the needs of Canada’s Dental Professional community. We have five core therapeutic areas offering the following exclusive brands; Pain Management, Ultracaine® ; Bone regeneration, Geistlich Biomaterials: Periodontal Disease Management, ARESTIN® Minocycline 1mg; Emergency Preparedness, LIGHTHOUSETM Emergency Kits and within Infection Control, SteriTestTM . Established in 1996, HANSAmed became the exclusive distributor of Ultracaine®, the world’s first articaine-based dental anesthetic. We grew with the addition of Arestin® for the adjunctive treatment of periodontal disease. We were proud to have … Type: | 2 | 1 | 1 | 45 |
 | Jenburkt Pharmaceuticals Limited Delivering Excellence in Life Sciences Our purpose at Jenburkt Pharmaceuticals Ltd is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. We believe in serving our patients – through them, we serve God, humanity and nation. Way back in the twentieth century, a visionary in the field of healthcare and philanthropic work – Shri Nandlal Mulji Bhuta laid the foundation for several companies. Today, with over 850+ committed team members across functions pan-India,we have 11 million+ prescriptions generated annually from 400,000+ pharmacies across the globe. Our organisation caters to large … Type: | 0 | 0 | 0 | 251 |
 | PolarSeal® Leading the way in flexible material converting by solving and serving the challenges and needs of our global customers. A medical flexible material converter and contract manufacturer serving global medical device and healthcare companies. From material slitting and die cutting through to lamination and printing, we are able to provide a full end-to-end solution for simple and complex projects. PolarSeal is solely focused on medical device contract manufacturing and healthcare material conversion. Maintaining the highest standards of quality is part of who we are and this fortifies our value of being the TRUSTED ADVISOR. Get in touch : enquiries@polarseal.net Wound … Type: | 2 | 0 | 2 | 45 |
 | Buckingham Healthcare Ltd Winners of Innovate UK Smart Award | Buckingham owns over 12 patented products and 10 international trademarks Established in 2003 – Buckingham Healthcare are an innovative designer and manufacturer of aids to daily living and healthcare related products based in Dorset. At Buckingham Healthcare you will find a growing range of products some of which are unique and brand new to the market and others which are long established favourites. Whatever your needs you can be confident that you are dealing with qualified healthcare professionals who will be able to provide you with knowledgeable answers to any of your questions … Type: | 0 | 0 | 0 | 4 |
 | Molecular Dimensions A CALIBRE SCIENTIFIC COMPANY Molecular Dimensions is a supplier of modern screens and reagents for protein structure determination by X-ray crystallography. We stock a wide variety of products for protein crystallography including bacterial growth media, ready-to-use selenomethioine expression media, crystallization screens, crystallization plates and cryocrystallography. We also supply crystal growth incubators and automated solutions for crystal growth imaging and analysis with UV fluorescence. Owing to our comprehensive range of products we are widely recognised as the world leader in membrane protein crystallization. Have any questions? Contact us at enquiries@moleculardimensions.com! Protein Crystallography, Structural Biology, Protein Expression Media, Custom Products, SILAC media, … Type: | 2 | 0 | 1 | 4 |
 | Hyderus As a global leader in healthcare marketing, we strive to connect more customers with medicines, vaccines and diagnostics Hyderus - A FINN Partners company is a specialised consultancy in four areas of communications and policy: 1. The rapid change in how decisions are made about health in Europe and other industrialised societies and how clients can influence these decisions 2. The evolution of public health issues in developing countries; how clients can help to inform the discussion on these problems and; how clients can become involved in finding answers 3. Public thinking about international political and development issues - especially … Type: | 0 | 0 | 0 | 10 |
 | Iksuda Therapeutics Creating class-leading ADCs with enhanced tumor specificity Through our highly experienced ADC Research & Development Team, we are building a pipeline of class-leading ADCs with superior therapeutic index (TI) for difficult-to-treat cancers. Our approach is to develop the best ADC for any given target or tumor sub-type rather than 'technology-driven ADCs'. All our ADCs incorporate tumor-selective release & activation of the most relevant payload according to mechanism, optimizing anti-cancer efficacy and enhancing patient safety. Antibody-Drug Conjugates, PermaLink™, Conjugation Chemistry, Cancer research, ADCs, Drug Development, Therapeutics, Antibodies, Toxins, Cancer Treatment, ADC Stability, Antibody Drug Conjugate, Drug Discovery, Biotechnology, Preclinical, Bioconjugation, Organic … Type: | 2 | 1 | 2 | 44 |
 | Proclinical Staffing At Proclinical Staffing, our life science recruitment services support our partners with permanent and contract vacancies by connecting them with specialist talent across the globe. Whether you are looking for a recruitment agency to support you with a single vacancy or you need to staff an entire new facility, we extend an expert hand to help you find the highly-skilled people you need. Operating exclusively within life sciences industry – from MedTech and Medical Devices to Pharma and Biotech – our experience, resources and dedication enable us to meet the unique needs of the competitive, fast-paced industry. Our worldwide connections … Type: | 3 | 1 | 2 | 62 |
 | RTC North 30 years helping businesses innovate - compete - grow RTC North is an independent company with a 34-year track record in helping organisations to innovate, compete and grow. Established in Sunderland in 1989 as one of 12 ‘Regional Technology Centres’, its advisors have since worked with over 25,000 businesses across the North of England on a one-to-one basis to drive innovation, business improvement, and growth. The company employs over 100 staff and its team possess multi-disciplinary and multi-sector backgrounds and is made up of entrepreneurs, technologists, engineers, scientists, and researchers. The company is also heavily involved in promoting the take … Type: | 11 | 1 | 7 | 130 |
 | International Biomedical Innovative products and technologies that result in the best outcomes for critically ill infants and their families. For over 35 years, International Biomedical has been providing solutions to the global health-care marketplace to meet the evolving needs of caregivers and their patients. Our commitment to quality, dependability, and service is our main focus. Our passion is to provide innovative products and technologies that will result in the best outcomes for the newborn infant, the critically ill, and their families. Infant transport incubators, Blood gas and chemistry monitors, Radiation attenuating surgical gloves, Phototherapy, Intubation, Video Laryngoscope, Swaddling, Infant Cooling, Brain Monitor, … Type: | 0 | 0 | 0 | 85 |
 | MUSCLE MILK MUSCLE MILK is a company based out of 4a Crown Road, Stoke On Trent, United Kingdom. Type: | 7 | 1 | 4 | 17 |
 | Zebra Translations Limited Because Not Everything in Life is Black and White We are a long established and experienced translation agency specialising exclusively in medical and pharmaceutical documentation. We have been providing top-quality translations since 1999, the year we formed. Zebra is a member of the Association of Translation Companies (ATC) and Federation of Small Businesses (FSB). Our senior in-house linguists are individual members of the Institute of Translation & Interpreting (ITI) and/or the Chartered Institute of Linguists (CIOL). If there's anything else you would like to know, please visit www.zebratranslations.uk or please call us on +44 (0) 1462 429713, we shall be … Type: | 5 | 0 | 5 | 5 |
 | Nuffield Health Highgate Hospital Building a healthier nation. At Highgate Hospital, we provide you with rapid access to London’s top Consultants across a wide range of medical & surgical specialities. With the support of our patient services & nursing teams, we are there to support you every step of the way – from consultation to treatment and aftercare. We are a leading hospital based in leafy Highgate, North London. Rated OUTSTANDING in the well-led domain and GOOD overall by the CQC, we are proud of our high standards of nursing care, clinical excellence, cutting edge technology and friendly atmosphere for patients. Our Mission Our … Type: | 1 | 1 | 1 | 93 |
 | SureScreen Diagnostics Innovation in Diagnostics SureScreen believe that early, accurate diagnosis is better than waiting for problems to arise, and a proactive approach greatly benefits people's health, identifies issues early in their development, prevents accidents from happening and has a positive effect on performance, productivity and reputation. Our mission is to provide the best quality diagnostic products that meet and exceed their customer's expectations at a fair price. SureScreen Diagnostics is an award-winning business that manufactures testing kits to be used by the patient side, which delivers quick and reliable results. Established in 1996, SureScreen has been providing proactive, bespoke diagnostic solutions … Type: | 3 | 0 | 0 | 56 |
 | Device Technologies Pioneering Possibility® For 32 years, Device Technologies has supplied the Australian healthcare community with quality and technologically advanced medical equipment, consumables, education and service. Proudly Australasian-owned, the company continues to grow, now employing more than 1000+ healthcare specialists and support staff across Australia, New Zealand, and Asia. In 2024, Device Technologies remains dedicated to the mission of enabling superior health outcomes for patients and their healthcare providers, by facilitating access to the best medical technology available worldwide. The company is united in its four core values to innovate, collaborate, take ownership, and consistently conduct good business. The extensive Device Technologies … Type: | 3 | 1 | 3 | 846 |
 | Medivir AB Improving life for cancer patients through transformative drugs Medivir develops innovative drugs with a focus on cancer where the unmet medical needs are high. The drug candidates are directed toward indication areas where available therapies are limited or missing and there are great opportunities to offer significant improvements to patients. Medivir is focusing on the development of fostroxacitabine bralpamide (fostrox), a smart, targeted chemotherapy designed to selectively treat liver cancer cells and to minimize side effects. Collaborations and partnerships are important parts of Medivir's business model, and the drug development is conducted either by Medivir or in partnership. Medivir's share … Type: | 1 | 1 | 1 | 47 |
 | EOFlow A South Korea-based medical devices company that offers innovative technology to streamline diabetes care management EOPatch(Wearable Insulin Pump) Manufacturer Type: | 2 | 2 | 0 | 22 |
 | AESGP Empowering Self-Care in Europe Established in 1964, the Association of the European Self-Care Industry (AESGP) represents the manufacturers of non-prescription medicines, food supplements and self-care medical devices (an area also referred to as consumer healthcare products). Our mission is to advance responsible self-care, enabling citizens to take better care of their health needs, and to contribute to the sustainability of European healthcare systems. OTC, Substance based MD, Non-prescription medicines, Pharmaceutical, Self-care, and Food supplement Type: | 9 | 1 | 8 | 20 |
 | Protein Sciences Corporation Protein Sciences (www.proteinsciences.com) is a biotechnology company that specializes in vaccine development and protein production. Our mission is our inspiration: to save lives and improve health by effectively responding to the changing world through the creation of innovative vaccines and biopharmaceuticals. See where Flublok® Influenza vaccine is available at www.flublok.com. We use our proprietary BEVS protein expression technology to produce high quality recombinant proteins quickly, reliably and at low cost. We have developed three main business lines that employ this technology: 1. Proprietary vaccines - we develop and produce the next generation of safer and more effective vaccines 2. GeneXpress® … Type: | 1 | 1 | 0 | 46 |
 | Sanofi Polska [Automatic translation follows] We chase the miracles of science to improve people’s lives. Sanofi is an innovative, global biopharmaceutical company with one goal: to change the world for the better by using the power of science, in accordance with the slogan “We chase the miracles of science to improve people’s lives”. In 100 countries, dedicated and talented teams are working to change the face of medicine, making the impossible possible. The company creates therapies and vaccines that save the lives of millions of people around the world. We have a wide range of specialist medicinal products and services in many … Type: | 17 | 3 | 11 | 164 |
 | La Jolla Institute for Immunology Dedicated to understanding the intricacies and power of the immune system; striving toward a Life Without Disease ®. "Sometimes in science there are so many people trying to answer the same question that it's good to stray off in another direction," Mitchell Kronenberg, Ph.D., LJI Professor. "Taking the road less traveled can bring its voyagers to unexpected - and even groundbreaking - new territory." The La Jolla Institute The La Jolla Institute for Immunology is a non-profit medical research institute dedicated to increasing knowledge and improving human health through studies of the immune system. Our essential purpose is to expand … Type: | 7 | 1 | 4 | 429 |
 | The EBMT We are a non-profit medical and scientific organisation for cellular and stem cell-based therapies. Join our community! The EBMT is a non-profit medical and scientific organisation established in 1974 which hosts a unique patient registry providing a pool of data to perform studies and assess new trends. We aim to be the connection between patients, researchers and other stakeholders to anticipate the future of cellular and stem cell-based therapies. Our community of healthcare professionals is focused on innovation, research and the advancement of these fields to save and improve the lives of patients with blood-related disorders. Visit www.ebmt.org to learn … Type: | 9 | 3 | 1 | 193 |
 | Grupo Español de Cáncer de Pulmón [Automatic translation follows] Lung Cancer Research The Spanish Lung Cancer Group (GECP) is a cooperative work and research group on this pathology made up of more than 460 professionals that enjoys a high position both nationally and internationally. Research to achieve more effective treatments against the disease is one of the main missions and values of the GECP. A work that is carried out from its administrative headquarters. Since its launch, the GECP headquarters has led, developed and monitored studies and trials in different clinical situations, from early stages of the disease to the most advanced, in which more than … Type: | 7 | 3 | 5 | 26 |
 | Sonoma Biotherapeutics Leading the Next Frontier of Cell Therapy Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle. cell therapy and autoimmune disease Type: | 1 | 1 | 1 | 131 |
 | Soi Dog Foundation 20 years saving Asia's dogs & cats through rescue, CNVR, treatment, shelter, adoption & ending the dog & cat meat trade Soi Dog’s mission is 'To improve the welfare of dogs and cats in Asia, resulting in better lives for both the animal and human communities, to create a society without homeless animals and to ultimately end animal cruelty'. Established in 2003 in Phuket, Thailand, Soi Dog is Southeast Asia's largest organisation helping stray animals. The sanctuary in Phuket is currently home to over 1,800 animals. Soi Dog also has a treatment facility in Bangkok and responds to crisis situations … Type: | 4 | 2 | 3 | 85 |
 | FARMAINDUSTRIA Innovation for people Created in 1963, Farmaindustria is the National Association of the Pharmaceutical Industry established in Spain. It brings together most of the innovative pharmaceutical laboratories established in Spain, which accounts for almost all sales of prescription drugs under patent in the country. farmacia, investigación y desarrollo, industria, innovación, salud, sanidad, health, pharma, healthcare, laboratorios, medicamentos, fármacos, pharmaceuticals, medicine, I+D, vacunas, vaccines, and industria farmacéutica Type: | 24 | 8 | 8 | 170 |
 | osteobionix From replacement to regeneration osteobionix is a company dedicated to advancing the standards of care for people suffering from cartilage or bone loss. Cartilage and bone loss may result from a variety of causes including osteoarthritis, trauma and tumor and can severely affect a person’s lifestyle. osteobionix wants to provide people suffering from cartilage or bone loss with innovative, high quality, proven, customized solutions, which can help them regain the lifestyle they deserve. osteobionix collaborates with surgeons in designing and manufacturing reliable, cost-effective solutions, which take into account the uniqueness and complexity of each single surgical case. osteobionix strives to … Type: | 0 | 0 | 0 | 10 |
 | AESEG [Automatic translation follows] We are the employers' association of the generic pharmaceutical industry in Spain. AESEG is the employers' association of the generic pharmaceutical industry in Spain and the qualified business interlocutor in this area. All pharmaceutical specialty laboratories, companies that manufacture raw materials and active pharmaceutical ingredients or technological development companies whose main activity is in the field of generics within the national territory can become members of AESEG. AESEG was established in Barcelona on March 17, 1998 as a national non-profit organization, to promote the knowledge and use of generic drugs, creating a true generic culture within Spanish … Type: | 4 | 1 | 4 | 11 |
 | SERAM - Sociedad Española de Radiología Médica [Automatic translation follows] Spanish Society of Medical Radiology (SERAM) SERAM is a medical-scientific and professional organization dedicated to promoting among its Members the teaching, development, defense and research of all diagnostic and therapeutic aspects related to medical imaging, making its activities known to the general population. Radiodiagnosis, Radiology, and Diagnostic Imaging Type: | 6 | 2 | 4 | 57 |
 | ChemoMetec We are a worldwide leading manufacturer in cell counting and analysis. Born in Scandinavia, operating globally. ChemoMetec is a worldwide leading manufacturer of cell counting and analysis equipment. We specialize in developing and producing high-precision instrumentation, delivering consistent data for thousands of customers across biotech, pharma and academic segments. We are experiencing exponential growth, as the company strives towards our goal to be the number one provider in Life Sciences. Designed, manufactured and tested in Denmark, our instruments and consumables are built with quality materials and dedicated expert workmanship. Find us on Glassdoor: https://bit.ly/3pjjzTA Manufacturing Cell Counters, Manufacturing Cell Analyzers, … Type: | 6 | 0 | 1 | 189 |
 | Zealand Pharma Changing lives with next generation peptide therapeutics Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on … Type: | 6 | 3 | 2 | 336 |
 | BVMed - Bundesverband Medizintechnologie [Automatic translation follows] BVMed is the voice of the German MedTech industry BVMed is the voice of the German MedTech industry. We represent more than 300 manufacturers, suppliers and dealers in the MedTech industry as well as medical device providers and homecare providers. About the industry: 265,000 employees | 93% SMEs | +40 billion € total turnover | 9% investment in R&D | 68% export Imprint: bvmed.de/impressum Medical devices, medical technology, CE marking, reimbursement, market access, reimbursement, benefit assessment, regulatory issues, and health policy Type: | 20 | 1 | 20 | 39 |
 | BASF Pharma Solutions Inspiring Medicines for better Lives BASF Pharma Solutions produces innovative excipients and active ingredients of outstanding quality and performance. With a global team of industry experts and digital solutions, BASF supports its customers in developing efficient, cost-effective and reliable formulations. Equipped with an in-depth understanding of multiple technologies and applications, we have the knowledge and resources to make pharmaceutical drug delivery and the manufacturing of drugs and biologics safer and more sustainable. We create solutions for Biopharma, Parenteral, Oral, Solubilization and Topical applications and are also a leading supplier of selected APIs such as ibuprofen, L-menthol and Omega-3. About BASF … Type: | 3 | 1 | 3 | 0 |
 | vly In our Berlin lab, we develop dairy alternatives that are both nutritious & delicious. Hi, we are vly [flaɪ]. You've probably seen our products before, either in your local supermarket or at the latest here on our LinkedIn. We are the creators of great-tasting dairy alternatives based on pea protein that are also highly nutritious. In fact, we are product developers who experiment with plant protein in the lab every day, generating what we like to call *The Next Generation of Dairy*. Simply because we load our products with nutrients like plant protein, fiber, and healthy fats while using less … Type: | 2 | 0 | 2 | 34 |
 | TME Pharma Developing novel therapies for treatment of the most aggressive cancers by acting on the tumor microenvironment (TME) TME Pharma is a clinical-stage company focusing on developing novel therapies for treatment of the most aggressive cancers. We specialize in approaches targeting the tumor microenvironment (TME) in which cancer cells exist. Our unique technology breaks tumor protection barriers against the immune system and blocks tumor repair by neutralizing chemokines in the TME. TME Pharma’s approach works in combination with other forms of treatment to weaken tumor defenses and enable greater therapeutic impact. TME Pharma’s mission is to improve treatment outcomes for patients … Type: | 4 | 1 | 2 | 19 |
 | action medeor e.V. Die Notapotheke der Welt. Founded 1964, the charitable, non-governmental organization action medeor e.V. today is the largest medical aid organization in Europe. action medeor supports around 10.000 healthcare facilities in 140 countries all over the world. Medical facilities receive drugs as well as medical equipment and supplies either at cost price or as donations. Our aid is supplied in co-operation with different church and secular organizations, religious communities, private initiatives and healthcare centers abroad. Based on many years’ experience, action medeor has built up a comprehensive network of facilities in the healthcare sector. Emergency and disaster relief In cases of … Type: | 2 | 1 | 2 | 65 |
 | SIRION BIOTECH GmbH (Revvity Gene Delivery) Any Gene to Any Cell Viral Vector Services from Vector Engineering and Manufacturing to Cell and Gene Therapy Development Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. Whether you need small scale viral production or full scale viral vector optimization and manufacture, our expert team has you covered. For additional information, please visit www.sirion-biotech.com. AAV, Lentivirus, Custom viral vectors, Virus production, AAV engineering for gene therapy, LentiBOOST, and Gene delivery Type: | 4 | 1 | 0 | 39 |
 | Tubulis GmbH Reimagining ADCs. Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. We will advance a range of conjugates, unlimited by indication, using our own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets. Antibody Drug Conjugates, Targeted Therapy, Biotechnology, and Drug Development Type: | 3 | 2 | 1 | 46 |
 | h/p/cosmos sports & medical gmbh ...run ahead of time! Performance diagnostics, exercise physiology, sports science, sports medicine, biomechanics, motion analysis, athletic training, fitness, CPET, neurologic and orthopedic diagnostics and rehabilitation devives and systems are in the focus of the German based manufacturer h/p/cosmos. Your treadmill specialist and ahead of time since 1988. h/p/cosmos stands for convincing technology, advanced design and safety in the production of running machines, treadmills, ladder-ergometers, sprint trainers (sprint ergometers), sports performance training and diagnostic systems as well as rehabilitation equipment. In the course of time, h/p/cosmos developed into a specialist for running machines and accessories in sports, medicine and research. Designed … Type: | 4 | 1 | 4 | 29 |
 | uniQure Transforming the lives of patients through gene therapy uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases. aav and lpl Type: | 2 | 2 | 0 | 430 |
 | Fraunhofer Institute for Interfacial Engineering and Biotechnology We combine biology and engineering The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB develops and optimizes processes, technologies, and products for health, sustainable chemistry and the environment. In doing so, we rely on the unique combination of expertise in biology and the engineering sciences in order to contribute to human welfare, a sustainable economy, and an intact environment with the systems approach of bioeconomy as well as bioinspired, biointegrated and biointelligent solutions. Working closely with partners from universities and industry, the IGB covers the entire innovation chain from fundamental research to industrial implementation. We provide our customers with research … Type: | 13 | 5 | 2 | 228 |
 | Bicoll We envision molecules for epilepsy and longevity: Research and development of novel patentable structures. Bicoll is an expert in bioactive plant-derived small molecules with outstanding expertise in high-tech natural product chemistry and validated experience in medicinal chemistry. Currently Bicoll focuses on two main fields such as neurodegenerative disorders (primarily, epilepsy) and longevity. In both of the fields it develops own preclinical candidates. Drug Discovery Services, Custom Synthesis, Medicinal Chemistry Services, Natural Product, Plant-based compounds, Food supplements, Nutraceuticals, and Cosmetics Type: | 2 | 0 | 0 | 14 |
 | Fuel Cell LLC HHO, H2, PEM, SOFC Bringing fuel cells and hydrogen production to the general market for anyone to be able to afford. Generally catering to the general market of more than a dozen various models ranging from small palm sized cells to large cells that will provide 20-50 LPM of Pure H2 or Hydrogen/Oxygen; we also specialize in separation cells and the advancement in PEM and SOFC technologies, lowering manufacturing costs while increasing efficiency so that such fuel cell technology can become a viable source of power generation for common usage. Hydrogen, PEM, SOFC, and Fuel Cells Type: | 0 | 0 | 0 | N/A |
 | CureVac We fight for human health - we are the RNA people CureVac (Nasdaq: CVAC) is a pioneering multinational biotech company founded in 2000 to advance the field of messenger RNA (mRNA) technology for application in human medicine. In more than two decades of developing, optimizing, and manufacturing this versatile biological molecule for medical purposes, CureVac has introduced and refined key underlying technologies that were essential to the production of mRNA vaccines against COVID-19, and is currently laying the groundwork for application of mRNA in new therapeutic areas of major unmet need. CureVac is leveraging mRNA technology, combined with advanced omics … Type: | 13 | 3 | 8 | 876 |
 | VITA34 AG [Automatic translation follows] We enable a more vital future for everyone. VITA 34 - THE FUTURE LIES IN LEIPZIG With the largest cell bank in the German-speaking region, Vita 34 is the expert in storing stem cells obtained from the umbilical cord at birth. Stem cells are already the basis of numerous medical applications. With personalized therapies tailored to individual needs, they will help shape the medicine of tomorrow. Since 1997, Vita 34 has been helping to make this vision a reality. As a full-service provider with around 100 employees, we provide services from collection to processing and preservation to … Type: | 1 | 1 | 0 | 47 |
 | CDR Companies Engineering Consulting Services, Emergency Management Solutions, Health & Medical Services, Financial Solutions, Labs Founded in 1938, CDR Maguire began as an engineering firm on the cornerstone of innovation and alternative delivery solutions. With offices across the nation, the firm has expanded to provide engineering consulting services, emergency management solutions, and disaster health and medical services, overseeing over $2 billion in construction, over $10 billion in disaster recovery, and $500 million in COVID-19 related medical services. CDR’s team of health and medical professionals are rethinking the way state and local governments provide access to quality medical care. Known for our response … Type: | 2 | 1 | 2 | 400 |
 | Oxford Biomedica A quality and innovation-led CDMO in cell and gene therapy OXB (LSE: OXB) is a quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. The Company collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, … Type: | 19 | 4 | 9 | 759 |
 | Klinikum Darmstadt GmbH [Automatic translation follows] Together for life. Together for life: The Darmstadt Clinic is the municipal maximum care provider in southern Hesse and the only hospital offering comprehensive emergency care (highest level of care). At the end of 2020, the Darmstadt Clinic opened its new central building: 1,000 modern beds in comfortable wards are available in one location in the middle of the city center. The hospital is characterized by modern medical technology, extensive digitization, comprehensive quality management, numerous certifications and a broad range of excellent hospital hygiene. Three large intensive care units, 21 clinics and institutes, from ophthalmology to the … Type: | 2 | 0 | 2 | 413 |
 | MagForce NT GmbH Pioneers in nanotechnology-based cancer treatment MagForce is forging new paths to treat cancer successfully and gently. With NanoTherm® Therapy System (NTTS), we have developed an innovative approach based on nanotechnology, which we want to make available to patients worldwide. And we are getting closer and closer to this goal. NTTS is the first and only nanotechnology-based therapy with European approval for treating recurrent Glioblastoma, a deadly brain tumor. To date, many patients diagnosed with Glioblastoma tumors have improved their quality of life after using our technology. Nanomedicine, Oncology, Brain Tumor, Nanotechnology, Glioblastoma, Prostate Cancer, Medical Devices, Medical Technology, and Thermotherapy Type: | 1 | 1 | 1 | 41 |
 | PromoCell Leading biotechnology company who supports scientists worldwide with high-end human cell culture products and services. At PromoCell, we help scientists do better research with a world-class portfolio of human primary, stem and blood cells as well as optimized cell culture media. With over 30 years of expertise, we are recognized globally for supplying scientists with the tools and support they need to do groundbreaking research. All our products comply with European biomedical conventions, ensuring human rights and donor privacy are always protected. Our ISO certifications demonstrate our absolute commitment to quality and our EXCiPACTTM GMP certification enables us to produce … Type: | 5 | 0 | 2 | 83 |
 | SFL is now Veristat Solutions For Life sciences SFL, a Veristat company - Integrated Solutions for Healthcare Products SFL is a leading consultancy providing integrated solutions to pharma, biotech and medtech companies for all product life cycle stages: Regulatory Affairs & Regulatory Intelligence, Quality & Supply Chain, Medical Writing, Public Affairs & Market Access, Pharmacovigilance, and Healthcare Compliance. In addition, SFL can act as marketing authorization applicant and MAH in Switzerland and the EU and conduct submissions to FDA, PMDA and Health Canada and other authorities. As a Veristat company, SFL clients also have access to a substantial range of clinical development services such … Type: | 10 | 0 | 10 | 426 |
 | European Academy of Allergy and Clinical Immunology - EAACI Dedicated to science - Committed to your health The European Academy of Allergy and Clinical Immunology (EAACI) is a non-profit organization active in the field of allergic and immunologic diseases such as asthma, rhinitis, eczema, occupational allergy, food and drug allergy and anaphylaxis. EAACI was founded in 1956 in Florence and has become the largest medical association in Europe in the field of allergy and clinical immunology. It includes over 12,000 members from 124 countries, as well as 74 National Allergy Societies. EAACI’s mission is to promote basic and clinical research; to collect, assess and diffuse scientific information; to act … Type: | 5 | 2 | 2 | 152 |
 | MedXCell SA The Cell Therapy Venture Builder MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities. Biotechnology, Cell Therapy, Immunotherapy, NK Cells, Mesenchymal Stromal Cells, Immuno-oncology, and Osteoarthritis Type: | 1 | 1 | 0 | 8 |
SMB